Friday, August 17, 2018

US FDA News: FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder

FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
Read more: FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder